Answers are grounded in this paper and cite their sources.
The COVID-19 pandemic demonstrated that vulnerability, rather than chronological age alone, is a major determinant of severe infectious-disease outcomes; yet adult vaccination policies remain largely based on age and selected medical conditions. This narrative review examines vulnerability as a multidimensional framework for adult vaccination and explores its implications for vaccine policy, healthy aging, and pandemic preparedness. We conducted a non-systematic search of PubMed, Scopus, and Google Scholar (January 2020–June 2026), complemented by a targeted consultation of institutional reports, and synthesized evidence on the biological, clinical, functional, and social determinants of vulnerability and their relationship to vaccination. Vulnerability emerged as a multidimensional construct in which immunosenescence, multimorbidity, frailty, and social disadvantage were consistently identified as major contributors to susceptibility to, and adverse outcomes of, infectious diseases such as COVID-19, influenza, respiratory syncytial virus, pneumococcal disease, and herpes zoster; these dimensions also shaped vaccine uptake, access, and effectiveness; and appeared to identify at-risk populations more accurately than age alone. Adult vaccination policies should therefore complement age-based recommendations with person-centered approaches incorporating multidimensional vulnerability assessment, which may improve vaccine equity, optimize protection among high-risk groups, help preserve functional independence, and strengthen pandemic preparedness. The development of a practical Vaccination Vulnerability Index warrants further investigation.
No takes yet. Share an insight, caveat, or question.
Ecarnot et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: